Full Access with Signal8 Pro, $49/mo billed annually.
Pulse Biosciences, Inc. is an innovative firm specializing in bioelectric medicine. Their primary offering is the CellFX System, a sophisticated, console-based platform that is precisely controlled via software. This system utilizes its proprietary Nano-Pulse Stimulation technology to deliver extremely brief, nanosecond-duration electrical pulses. This advanced method is designed to selectively eliminate target cells without thermal damage, effectively safeguarding adjacent non-cellular tissue. The CellFX System is applied in the treatment of various medical conditions. The company, originally incorporated in 2014 as Electroblate, Inc., officially became Pulse Biosciences, Inc. in December 2015. Its corporate headquarters are situated in Hayward, California.
Sector: Surgical & Medical Instruments & Apparatus
Industry: Medical - Instruments & Supplies
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
based on 71.32M shares outstanding
Pulse Biosciences, Inc. is an innovative firm specializing in bioelectric medicine. Their primary offering is the CellFX System, a sophisticated, console-based platform that is precisely controlled via software. This system utilizes its proprietary Nano-Pulse Stimulation technology to deliver extremely brief, nanosecond-duration electrical pulses. This advanced method is designed to selectively eliminate target cells without thermal damage, effectively safeguarding adjacent non-cellular tissue. The CellFX System is applied in the treatment of various medical conditions.
The company, originally incorporated in 2014 as Electroblate, Inc., officially became Pulse Biosciences, Inc. in December 2015.
Its corporate headquarters are situated in Hayward, California.
Darrin R. Uecker
Chief Technology Officer & Director
Mahkam Zanganeh, D.D.S.
Director; Co-Chief Executive Officer of Summit Therapeutics Inc. and Founder/Chief Executive Officer of Maky Zanganeh and Associates
Maria Sainz
Director; Chief Executive Officer & President of HYPERFINE, Inc.
Paul A. LaViolette
Co-Chairman of the Board of Directors, Chief Executive Officer and President; Chief Executive Officer, President & Co-Chairman of the Board of Directors
Employees
116
Country
US
Sector
Healthcare
Website
pulsebiosciences.com
Loading congressional disclosures…
based on 71.32M shares outstanding
30d Avg
525.21K
60d Avg
561.66K
90d Avg
509.48K